Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources

Jacek Capala; Stephen A. Graves; Aaron Scott; George Sgouros; Sara St. James; Pat Zanzonico; Brian E. Zimmerman

doi:10.2967/jnumed.121.262749

Research ArticleClinical (Radiobiology/Dosimetry/Safety)

Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources

Jacek Capala, Stephen A. Graves, Aaron Scott, George Sgouros, Sara St. James, Pat Zanzonico and Brian E. Zimmerman

Journal of Nuclear Medicine December 2021, 62 (Supplement 3) 3S-11S; DOI: https://doi.org/10.2967/jnumed.121.262749

Jacek Capala

1National Cancer Institute, Bethesda, Maryland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stephen A. Graves

2University of Iowa, Iowa City, Iowa;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aaron Scott

3Johns Hopkins University, Baltimore, Maryland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

George Sgouros

3Johns Hopkins University, Baltimore, Maryland;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sara St. James

4University of California, San Francisco, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pat Zanzonico

5Memorial Sloan Kettering Cancer Center, New York, New York; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Brian E. Zimmerman

6National Institute of Standards and Technology, Gaithersburg, Maryland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Information

vol. 62 no. Supplement 3 3S-11S

DOI

https://doi.org/10.2967/jnumed.121.262749

PubMed

34857621

Published By

Society of Nuclear Medicine

Print ISSN

0161-5505

Online ISSN

2159-662X

History

Received for publication June 30, 2021
Revision received October 22, 2021
Published online December 2, 2021.

Author Information

Jacek Capala¹,
Stephen A. Graves²,
Aaron Scott³,
George Sgouros³,
Sara St. James⁴,
Pat Zanzonico⁵ and
Brian E. Zimmerman⁶

¹National Cancer Institute, Bethesda, Maryland;
²University of Iowa, Iowa City, Iowa;
³Johns Hopkins University, Baltimore, Maryland;
⁴University of California, San Francisco, California;
⁵Memorial Sloan Kettering Cancer Center, New York, New York; and
⁶National Institute of Standards and Technology, Gaithersburg, Maryland

For correspondence or reprints, contact Pat Zanzonico (zanzonip{at}mskcc.org).

View Full Text

Statistics from Altmetric.com

Cited By...

7 Citations
9 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Dosimetry in Radiopharmaceutical Therapy

Joe O’Donoghue, Pat Zanzonico, John Humm, Adam Kesner

Journal of Nuclear Medicine 2022 63 10
Individualization of Radionuclide Therapies: Challenges and Prospects

Hanna Piwowarska-Bilska, Sara Kurkowska, Bozena Birkenfeld

Cancers 2022 14 14
Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation

Juan Sun, Zhenyuan Huangfu, Jiangtao Yang, Guanglin Wang, Kuan Hu, Mingyuan Gao, Zhiyuan Zhong

Advanced Drug Delivery Reviews 2022 190
The Impact of Radiopharmaceutical Therapy on Renal Function

Eunkyung Angela Park, Stephen A. Graves, Yusuf Menda

Seminars in Nuclear Medicine 2022 52 4
Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment

Caroline P. Kerr, Joseph J. Grudzinski, Thanh Phuong Nguyen, Reinier Hernandez, Jamey P. Weichert, Zachary S. Morris

Pharmaceutics 2022 15 1
A Primer on Radiopharmaceutical Therapy

Kilian E. Salerno, Soumyajit Roy, Cathy Ribaudo, Teresa Fisher, Ravi B. Patel, Esther Mena, Freddy E. Escorcia

International Journal of Radiation Oncology*Biology*Physics 2023 115 1
Nuclear Medicine and Molecular Imaging

Cinzia Pettinato, Elisa Richetta, Marta Cremonesi

2022
Patient-specific biokinetics and hybrid 2D/3D approach integration in OEDIPE software: Application to radioiodine therapy

M. Bensiali, N. Anizan, S. Leboulleux, S. Lamart, E. Davesne, D. Broggio, A. Desbrée, D. Franck

Physica Medica 2022
Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs

Diane K. Soulek, Molly E. Martin, Nic J. Mastascusa, Stephen A. Graves

Journal of Nuclear Medicine Technology 2022 50 3

Article usage

Article usage: December 2021 to December 2022

	Abstract	Full	Pdf
Dec 2021	2100	219	218
Jan 2022	570	192	108
Feb 2022	341	184	94
Mar 2022	281	216	120
Apr 2022	206	185	98
May 2022	148	127	73
Jun 2022	52	209	69
Jul 2022	63	216	72
Aug 2022	51	167	67
Sep 2022	58	162	73
Oct 2022	68	165	80
Nov 2022	64	193	86
Dec 2022	46	115	58

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 62, Issue Supplement 3

December 1, 2021

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources